Cemex SAB de CV (CXMSF) stock analysis
Close on Oct 19, 2026Market cap $15.36BP/E 48.6Yield –
StockData Score
Prices as of Nov 3, 2026How the score works
Weak5 of 30 checks passed
Cemex SAB de CV passes 5 of the 30 checks behind our score; 16 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 0/6
- Past performance
- 3/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Debt covered by cash flow
Operating cash flow over the last twelve months equals 35.0% of total debt.
Return on equity above the industry
Cemex SAB de CV's return on equity of 7.5% is above the Materials median of 5.1%.
Net margin above its 5-year average
Net margin was 6.0% over the last twelve months, against a 5-year average of 4.8%.
Net margin above the industry
Cemex SAB de CV's net margin of 6.0% is above the Materials median of 2.8%.
What to watch
Return on equity under 15%
Return on equity was 7.5% over the last twelve months and averaged 6.8% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 3.0%, below the 10% that usually covers the cost of capital.
High debt
Debt is 42.3% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew 3.1% a year over the last three fiscal years, short of the 10% we look for.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth0/6
Revenue growing under 10% a year
Revenue grew 3.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 4.1% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 0.4% over the last twelve months; the Materials median is 2.3%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin slipping
Gross margin was 32.9% over the last twelve months, against 33.7% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 7.5% over the last twelve months and averaged 6.8% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 3.0%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Cemex SAB de CV's return on equity of 7.5% is above the Materials median of 5.1%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 6.0% over the last twelve months, against a 5-year average of 4.8%.
Net margin above the industry
Cemex SAB de CV's net margin of 6.0% is above the Materials median of 2.8%.
Financial health2/6
High debt
Debt is 42.3% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 116% five years ago to 42.3%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 35.0% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets don't cover short-term debts
Current assets are 0.83 times current liabilities.
Bankruptcy risk (Altman Z)
Needs market value, working capital and retained earnings.
Dividend0/6
No dividend
Cemex SAB de CV has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Cemex SAB de CV. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $76.02M
- Value traded per 1% price move
- $43.34M
Downside
Medium risk
- Typical loss in a bad month
- 17.4%
- Volatility (annualized)
- 37%
- Sharpe ratio, 1 year
- -0.00
- Beta to the S&P 500 (5Y)
- 1.27
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2015 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +0.4% | +3.1% | +5.0% | – | |
| Gross profit | -1.8% | +5.8% | +5.4% | – | |
| Operating income | -44.8% | +4.8% | – | – | |
| Net income | +2.2% | +3.8% | – | – | |
| EPS, diluted | +2.3% | +4.1% | – | – | |
| Free cash flow | +3.6% | +18.8% | -0.5% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -16.9% | 7.5% | |
| Return on assets | – | -5.2% | 3.4% | |
| Current ratio | 0.99 | 0.79 | 0.83 | |
| Debt to equity | 1.45 | 1.16 | 0.42 | |
| Net debt to EBITDA | – | 13.23× | 1.66× | |
| Inventory turnover | – | 8.8× | 7.2× | |
| Capex to revenue | – | 4.2% | 5.9% | |
| Diluted shares | 48.67B | 44.87B | 44.08B |
Where the cash went
Fiscal 2021 to 2025, five years combined
Cemex SAB de CV generated $9.45B from operations and spent $4.65B on capital expenditure, dividends and share buybacks. 93% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 6.0% | 0.57× | 2.21× | 7.5% |
| FY2024 | 5.8% | 0.58× | 2.33× | 7.8% |
| FY2023 | 1.1% | 0.60× | 2.46× | 1.6% |
| FY2022 | 5.8% | 0.55× | 2.61× | 8.4% |
| FY2021 | 5.2% | 0.53× | 3.02× | 8.4% |
| FY2020 | -11.6% | 0.45× | 3.26× | -16.9% |
| FY2019 | 1.1% | 0.44× | 3.11× | 1.5% |
| FY2018 | 3.9% | 0.46× | 3.19× | 5.7% |
| FY2017 | 6.1% | 0.43× | 3.54× | 9.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$960.00M
- Cash generatingOperating cash flow above zero$1.98B
- Return on assets improvedROA up on the prior year3.3% → 3.5%
- Earnings backed by cashOperating cash flow above net income$1.98B vs $960.00M
- Less leverageLong-term debt to assets fell19.6% → 15.4%
- Better liquidityCurrent ratio rose0.82 → 0.83
- No dilutionShare count did not rise44.07B → 44.08B
- Gross margin improvedGross margin up on the prior year33.67% → 32.92%
- More efficientAsset turnover rose0.56 → 0.59
See a number that looks wrong?